1. Enthoven P, Skargren E, Carstensen J, Oberg B. Predictive factors for 1-year and 5-year outcome for disability in a working population of patients with low back pain treated in primary care. Pain. 2006; 122: 137-44.
2. Bone M, Critchley P, Buggy DJ. Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study. Regional Anesthesia and Pain Medicine. 2002; 27: 481-6.
3. Andersson GB, Mekhail NA, Block JE. Treatment of intractable discogenic low back pain. A systematic review of spinal fusion and intradiscal electrothermal therapy (IDET). Pain Physician. 2006; 9: 237-48.
4. Williams KA, Petronis J, Smith D et al. Effect of Iyengar yoga therapy for chronic low back pain. Pain. 2005; 115: 107-17.
5. Abbot NC, Harkness EF, Stevinson C et al. Spiritual healing as a therapy for chronic pain: a randomized, clinical trial. Pain. 2001; 91: 79-89.
* 6. Finnerup NB, Otto M, McQuay HJ et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005; 118: 289-305.
7. Lord SM, Barnsley L, Wallis BJ et al. Percutaneous radio-frequency neurotomy for chronic cervical zygapophyseal-joint pain. New England Journal of Medicine. 1996; 335: 1721-6.
8. Carragee EJ, Lincoln T, ParmarVS, Alamin T. A gold standard evaluation of the "discogenic pain'' diagnosis as determined by provocative discography. Spine. 2006; 31: 2115-23.
9. Rhodin A, Gronbladh L, Nilsson LH, Gordh T. Methadone treatment of chronic non-malignant pain and opioid dependence - A long-term follow-up. European Journal of Pain. 2006; 10: 271-8.
10. Gordon DB, Dahl JL. Quality improvement challenges in pain management. Pain. 2004; 107: 1-4.
* 11. Okifuji A, Turk DC. Assessment of treatment outcomes in clinical practice: A survival guide. In: Turk DC, Melzack R (eds). Handbook of pain assessment, 2nd edn. New York: Guilford, 2001: 639-58.
12. Rice ASC, Maton S. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain. 2001; 94: 215-24.
13. Rice ASC, Maton S. Response to comment on Rice ASC, Maton S, the Postherpetic Neuralgia Study Group (UK), Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo-controlled study (Pain 2001; 94: 215-24). Pain. 2002; 96: 411-12.
14. Serpell MG. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain. 2002; 99: 557-66.
15. Richeimer SH, Bajwa ZH, Kahraman SS et al. Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey. Clinical Journal of Pain. 1997; 13: 324-9.
* 16. Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clinical Journal of Pain. 2002; 18: 355-65.
17. Hatten AL, Gatchel RJ, Polatin PB, Stowell AW. A cost-utility analysis of chronic spinal pain treatment outcomes: converting SF-36 data into quality-adjusted life years. Clinical Journal of Pain. 2006; 22: 700-11.
18. Willich SN, Reinhold T, Selim D et al. Cost-effectiveness of acupuncture treatment in patients with chronic neck pain. Pain. 2006; 125: 107-13.
19. Thompson D. Toward a pharmacoeconomic model of neuropathic pain. Clinical Journal of Pain. 2002; 18: 366-72.
20. Cepeda MS, Farrar JT. Economic evaluation of oral treatments for neuropathic pain. Journal of Pain. 2006; 7: 119-28.
21. Chapman CR, Dunbar PJ. Measurement in pain therapy: is pain relief really the endpoint? Current Opinion in Anaesthesiology. 1998; 11: 533-7.
22. Walker J, Sofaer B, Holloway I. The experience of chronic back pain: Accounts of loss in those seeking help from pain clinics. European Journal of Pain. 2006; 10: 199-207.
23. McCracken LM, Eccleston C. A prospective study of acceptance of pain and patient functioning with chronic pain. Pain. 2005; 118: 164-9.
24. Sletten C. Outcome measurement in chronic pain. In: Jensen T, Wilson P, Rice A (eds). Chronic pain. In: Rice A, Warfield C, Justins D, Eccleston C (eds). Clinical Pain Management. London: Arnold, 2003: 145-53.
* 25. Dworkin RHP, Katz JP, Gitlin MJMD. Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain. Neurology. 2005; 65: S7-19.
26. Stroud MW, Thorn BE, Jensen MP, Boothby JL. The relation between pain beliefs, negative thoughts, and psychosocial functioning in chronic pain patients. Pain. 2000; 84: 347-52.
27. Luime JJ, Koes BW, Miedem HS et al. High incidence and recurrence of shoulder and neck pain in nursing home employees was demonstrated during a 2-year follow-up. Journal of Clinical Epidemiology. 2005; 58: 407-13.
28. Lipton RB, Bigal ME, Stewart WF. Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life. Neurology. 2005; 65: S50-8.
29. Zakrzewska JM, Lopez BC. Quality of reporting in evaluations of surgical treatment of trigeminal neuralgia: recommendations for future reports. Neurosurgery. 2003; 53: 110-22.
von Baeyer CL, Spagrud LJ. Systematic review of observational (behavioral) measures of pain for children and adolescents aged 3 to 18 years. Pain. 2007; 127: 140-50.
Eccleston C, Jordan A, McCracken LM et al. The Bath Adolescent Pain Questionnaire (BAPQ): development and preliminary psychometric evaluation of an instrument to assess the impact of chronic pain on adolescents. Pain. 2005; 118: 263-70.
Weiner DK. Improving pain management for older adults: an urgent agenda for the educator, investigator, and practitioner. Pain. 2002; 97: 1-4. Stolee P, Hillier LM, Esbaugh J et al. Instruments for the assessment of pain in older persons with cognitive impairment. Journal of the American Geriatrics Society. 2005; 53: 319-26.
Edwards C, Keefe F. New directions in research on pain and ethnicity: a comment on Riley, Wade, Myers, Sheffield, Pappas, and Price (2002). Pain. 2002; 100: 211-12. Rollman GB. The need for ecological validity in studies of pain and ethnicity. Pain. 2005; 113: 3-4. IMMPACT. The initiative on methods, measurement and pain assessment in clinical trials. Cited January 2008. Available from: www.immpact.org. Turk DC, Dworkin RH, Allen RR et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003; 106: 337-45. Dworkin RH, Turk DC, Farrar JT et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005; 113: 9-19. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale multidimensional pain inventory (WHYMPI). Pain. 1985; 23: 345-56.
Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Annals of the Academy of Medicine, Singapore. 1994; 23: 129-38.
Cleeland CS, Nakamura Y, Mendoza TR et al. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain. 1996; 67: 267-73.
Beck AT, Ward CH, Mendelson M et al. An inventory for measuring depression. Archives of General Psychiatry. 1961; 4: 561-71.
McNair DM, Lorr M, Droppleman LF. Profile of mood states. San Diego, CA: Educational and Industrial Testing Service, 1971.
Guy W. ECDEU assessment manual for psychopharmacology. DHEW Publication No. ADM 76-338. Washington DC: US Government Printing Office, 1976.
Moher D, Schulz KF, Altman D, for the CG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Journal of the American Medical Association. 2001; 285: 1987-91.
McQuay H. Consensus on outcome measures for chronic pain trials. Pain. 2005; 113: 1-2.
47. Tulen JHM, Stronks DL, Bussmann JBJ et al. Towards an objective quantitative assessment of daily functioning in migraine: a feasibility study. Pain. 2000; 86: 139-49.
48. Ferrer M, Pellise F, Escudero O et al. Validation of a minimum outcome core set in the evaluation of patients with back pain. Spine. 2006; 31: 1372-9.
49. Kalso E, Smith L, McQuay HJ, Andrew Moore R. No pain, no gain: clinical excellence and scientific rigour - lessons learned from IA morphine. Pain. 2002; 98: 269-75.
* 50. Farrar JT, Young J, James P et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001; 94: 149-58.
51. Dionne RA, Bartoshuk L, Mogil J, Witter J. Individual responder analyses for pain: does one pain scale fit all? Trends in Pharmacological Sciences. 2005; 26: 125-30.
52. Macfarlane GJ, Jones GT, Hannaford PC. Managing low back pain presenting to primary care: Where do we go from here? Pain. 2006; 122: 219-22.
53. Rosier EM, ladarola MJ, Coghill RC. Reproducibility of pain measurement and pain perception. Pain. 2002; 98: 205-16.
54. Kallai I, Barke A, Voss U. The effects of experimenter characteristics on pain reports in women and men. Pain. 2004; 112: 142-7.
* 55. Moore RA, Gavaghan D, Tramer MR et al. Size is everything
- large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain. 1998; 78: 209-16.
56. Gillespie R. Manufacturing knowledge: a history of the Hawthorne experiments. Cambridge: Cambridge University Press, 1991.
57. Lines CR, Vandormael K, Malbecq W. A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients. Pain. 2001; 93: 185-90.
58. Anderson KO. Role of cutpoints: why grade pain intensity? Pain. 2005; 113: 5-6.
* 59. Williams ACdC, Davies HTO, Chadury Y. Simple pain rating scales hide complex idiosyncratic meanings. Pain. 2000; 85: 457-63.
60. Jensen MP, Turner JA, Romano JM, Fisher LD. Comparative reliability and validity of chronic pain intensity measures. Pain. 1999; 83: 157-62.
61. Collins SL, Edwards J, Moore RA et al. Seeking a simple measure of analgesia for mega-trials: is a single global assessment good enough? Pain. 2001; 91: 189-94.
62. Haas M, Nyiendo J, Aickin M. One-year trend in pain and disability relief recall in acute and chronic ambulatory low back pain patients. Pain. 2002; 95: 83-91.
63. Cook AJ, Roberts DA, Henderson MD et al. Electronic pain questionnaires: A randomized, crossover comparison with paper questionnaires for chronic pain assessment. Pain. 2004; 110: 310-17.
64. Palermo TM, Valenzuela D, Stork PP. A randomized trial of electronic versus paper pain diaries in children: impact on compliance, accuracy, and acceptability. Pain. 2004; 107: 213-19.
* 65. Morley S, Williams ACdC. RCTs of psychological treatments for chronic pain: Progress and challenges. Pain. 2006; 121: 171-2.
66. Polomano RC, Marcotte PJ, Farrar JT. Spinal fusion or exercise and cognitive intervention? In search of the answers. Pain. 2006; 122: 4-5.
67. Zucker DR, Ruthazer R, Schmid CH et al. Lessons learned combining n-of-1 trials to assess fibromyalgia therapies. Journal of Rheumatology. 2006; 33: 2069-77.
68. Nikles CJ, Yelland M, Glasziou PP, Del Mar C. Do individualized medication effectiveness tests (n-of-1 trials) change clinical decisions about which drugs to use for osteoarthritis and chronic pain? American Journal of Therapeutics. 2005; 12: 92-7.
69. Nikles CJ, Yelland M, Del Mar C, Wilkinson D. The role of paracetamol in chronic pain: an evidence-based approach. American Journal of Therapeutics. 2005; 12: 80-91.
70. Wegman AC, van der Windt DA, de Haan M et al. Switching from NSAIDs to paracetamol: a series of n of 1 trials for individual patients with osteoarthritis. Annals of the Rheumatic Diseases. 2003; 62: 1156-61.
71. Williams ACdC, Nicholas MK, Richardson PH et al. Generalizing from a controlled trial: the effects of patient preference versus randomization on the outcome of inpatient versus outpatient chronic pain management. Pain. 1999; 83: 57-65.
Thimineur MA, Kravitz E, Vodapally MS. Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study. Pain. 2004; 109: 242-9. Brox JI, Reikeras O, Nygaard O et al. Lumbar instrumented fusion compared with cognitive intervention and exercises in patients with chronic back pain after previous surgery for disc herniation: A prospective randomized controlled study. Pain. 2006; 122: 145-55.
74. Fairbank J, Frost H, Wilson-MacDonald J et al. Randomised controlled trial to compare surgical stabilisation of the lumbar spine with an intensive rehabilitation programme for patients with chronic low back pain: the MRC spine stabilisation trial. British Medical Journal. 2005; 330: 1233.
76. Vase L, Riley III JL, Price DD. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain. 2002; 99: 443-52.
77. Turner JA, Jensen MP, Warms CA, Cardenas DD. Blinding effectiveness and association of pretreatment expectations with pain improvement in a double-blind randomized controlled trial. Pain. 2002; 99: 91-9.
78. Gilron I, Bailey JM, Tu D et al. Morphine, gabapentin, or their combination for neuropathic pain. New England Journal of Medicine. 2005; 352: 1324-34.
79. Black DR, Sang CN. Advances and limitations in the evaluation of analgesic combination therapy. Neurology. 2005; 65: S3-6.
80. Haythornthwaite JAP. Clinical trials studying pharmacotherapy and psychological treatments alone and together. Neurology. 2005; 65: S20-31.
* 81. McQuay HJ, Moore RA. An evidence-based resource for pain relief. Oxford: Oxford University Press, 1998.
* 82. Casarett D, Karlawish J, Sankar P et al. Designing pain research from the patient's perspective: what trial end points are important to patients with chronic pain? Pain Medicine. 2001; 2: 309-16.
83. Rowbotham MC. What is a 'clinically meaningful' reduction in pain? Pain. 2001; 94: 131-2.
84. ten Klooster PM, Drossaers-Bakker KW, Taal E, van de Laar MAFJ. Patient-perceived satisfactory improvement (PPSI): Interpreting meaningful change in pain from the patient's perspective. Pain. 2006; 121: 151-7.
85. Forouzanfar T, Weber WEJ, Kemler M, van Kleef M. What is a meaningful pain reduction in patients with complex regional pain syndrome type 1? Clinical Journal of Pain. 2003; 19: 281-5.
86. Robinson ME, Brown JL, George SZ et al. Multidimensional success criteria and expectations for treatment of chronic pain: the patient perspective. Pain Medicine. 2005; 6: 336-45.
87. Yelland MJ, Schluter PJ. Research: Defining worthwhile and desired responses to treatment of chronic low back pain. Pain Medicine. 2006; 7: 38-45.
* 88. Petrie KJ, Frampton T, Large RG et al. What do patients expect from their first visit to a pain clinic? Clinical Journal of Pain. 2005; 21: 297-301.
89. Ostelo RW, de Vet HC. Clinically important outcomes in low back pain. Best Practice and Research. Clinical Rheumatology. 2005; 19: 593-607.
90. Hirsh AT, Atchison JW, Berger JJ et al. Patient satisfaction with treatment for chronic pain: predictors and relationship to compliance. Clinical Journal of Pain. 2005; 21: 302-10.
91. Felson DT, Anderson JJ, Boers M et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis and Rheumatism. 1995; 38: 727-35.
92. Mannion AF, Elfering A, Staerkle R et al. Outcome assessment in low back pain: how low can you go? European Spine Journal. 2005; 14: 1014-26.
93. Du Pen S, Du Pen A, Hillyer J. Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study. Pain Medicine. 2006; 7: 10-15.
94. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. British Medical Journal. 1995; 310: 452-4.
95. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Annals of Internal Medicine. 1997; 126: 712-20.
96. Tramer MR, Glynn CJ. Magnesium bier's block for treatment of chronic limb pain: a randomised, doubleblind, cross-over study. Pain. 2002; 99: 235-41.
97. Altman DG. Confidence intervals for the number needed to treat. British Medical Journal. 1998; 317: 1309-12.
98. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 1999; 83: 389-400.
* 99. Bandolier. Number needed to treat (NNT) (electronic version). Cited October 2006. Available from: www.jr2.ox.ac.uk/bandolier/band59/NNT1.html.
100. Farrar JT, Dworkin RH, Max MB. Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable. Journal of Pain and Symptom Management. 2006; 31: 369-77.
101. L'Abbe KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Annals of Internal Medicine. 1987; 107: 224-33.
102. Rivero-Arias O, Gray A, Frost H et al. Cost-utility analysis of physiotherapy treatment compared with physiotherapy advice in low back pain. Spine. 2006; 31: 1381-7.
103. Frost H, Lamb SE, Doll HA et al. Randomised controlled trial of physiotherapy compared with advice for low back pain. British Medical Journal. 2004; 329: 708.
This page intentionally left blank
MANAGEMENT - THERAPIES
15 The use of NSAIDs and paracetamol (acetaminophen) in chronic pain 193
John Hughes and K Riaz Khan
16 Opioids and chronic noncancer pain 207
C Roger Goucke and Eric J Visser
17 Topical analgesics for neuropathic pain 230
Charles E Argoff and K Riaz Khan
18 Chronic pain and depression 241
W Michael Hooten
19 Antiepileptic and antiarrhythmic agents 254
Turo J Nurmikko
20 Neurostimulation techniques 268
Marc A Huntoon
21 Spinal administration 284
Kate Grady and Jon Raphael
22 Cognitive-behavior therapy for chronic pain in adults 292
Stephen Morley and Christopher Eccleston
23 Evaluation of complementary and alternative therapies 303
Miles J Belgrade and Cassandra D Schamber
This page intentionally left blank
Was this article helpful?
It's time for a change. Finally A Way to Get Pain Relief for Your Arthritis Without Possibly Risking Your Health in the Process. You may not be aware of this, but taking prescription drugs to get relief for your Arthritis Pain is not the only solution. There are alternative pain relief treatments available.